Related Experiment Videos

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

Sho-ichi Yamagishi1, Tsutomu Imaizumi

  • 1Department of Internal Medicine III, Kurume University School of Medicine, Japan. shoichi@med.kurume-u.ac.jp

Insights

Diabetic vascular complications, a major cause of diabetes-related morbidity and mortality, are driven by chronic hyperglycemia. Understanding these molecular mechanisms is key to developing new therapies for diabetes complications.

Area of Science:

  • Endocrinology
  • Vascular Biology
  • Diabetology

Background:

  • Diabetic vascular complications contribute significantly to end-stage renal failure, blindness, neuropathy, and atherosclerosis.
  • These complications lead to substantial disability and mortality in diabetic patients.
  • While intensive glucose control benefits microvascular outcomes, macrovascular complications involve insulin resistance and postprandial hyperglycemia.

Purpose of the Study:

  • To summarize the molecular mechanisms underlying diabetic vascular complications.
  • To explore potential therapeutic interventions for preventing these disorders, even when hyperglycemia is difficult to control.

Main Methods:

  • Review of molecular mechanisms initiated by chronic hyperglycemia.
  • Analysis of pathways including advanced glycation end products, protein kinase C, polyol pathway, and reactive oxygen species.
  • Examination of the role of vascular inflammation, gene expression, and cellular activation.

Main Results:

  • Chronic hyperglycemia initiates vascular complications through multiple molecular pathways.
  • These pathways regulate vascular inflammation, alter growth factor and cytokine expression, and activate platelets and macrophages.
  • High glucose plays a central role in the development and progression of diabetic vascular complications.

Conclusions:

  • Understanding the molecular basis of diabetic vascular complications is crucial.
  • Targeting these mechanisms may offer therapeutic strategies to prevent or mitigate complications.
  • Novel interventions are needed to manage hyperglycemia and its vascular consequences effectively.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...